Who Paid My Doc
Acp-103-047
ClinicalTrials.gov NCT03325556
Research payments
$2,548,458
Through program year 2022, $2,548,458 in research payments was reported against Acp-103-047, across 258 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT03325556
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $999,792 | 59 |
| 2021 | Research | $501,176 | 55 |
| 2020 | Research | $633,543 | 82 |
| 2019 | Research | $413,947 | 62 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Pilar Trueba Doral, FL Named on 37 payments
- Miguel Perez Hialeah, FL Named on 33 payments
- John Duffy Tustin, CA Named on 29 payments
- Mark Hernandez Hialeah, FL Named on 19 payments
- Shivkumar Hatti Media, PA Named on 16 payments
- Mark Stillman Cleveland, OH Named on 16 payments
- Aniel Navarro Marin Miami, FL Named on 12 payments
- Jean Fils Tampa, FL Named on 12 payments
- Kenia Castro Miami, FL Named on 11 payments
- Ayesha Lall Gainesville, FL Named on 10 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.